Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer.

Cancer Chemother Pharmacol · 2025 · PMC12672692 · PMID 41331382

Europe PMC DOI

hedged sentence

0.3900

closest p · 7.8× alpha

0.3900

boldest claim

The sentences

did not reach statistical significancep = 0.39not close (p > 0.1)

Reductions did not reach statistical significance between the three groups, as well as discontinuation ( p = 0.39 and p = 0.81, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.